Experts express concern about Biden's plan to release nearly all available vaccine doses

President-elect Joe Biden plans to release nearly every available dose of the Pfizer-BioNTech and Moderna COVID-19 vaccines when he takes office later this month rather than holding back millions of second doses, his transition team said Friday. The decision is meant to "ensure the Americans who need it most get it as soon as possible."
The Trump administration has insisted it's necessary to retain second doses, with Health and Human Services Secretary Alex Azar on Friday expressing concern that Biden's plan could backfire if there are any manufacturing mishaps.
Outside of the White House, Dr. Leana Wen of George Washington University, was also apprehensive, noting that there is "an ethical consideration" since those who volunteered for the initial dose were reasonably expecting to receive the second in the proper amount of time. Biden does not intend to delay the second shot for those patients, and is instead counting on an increased production to keep pace. But, Wen says, not only is there no guarantee of a smooth manufacturing process, much of the slowdown has occurred between distribution and injection, so until that stage improves the risk of delay remains.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Harvard University's Juliette Kayyem, however, is more on board with the plan. She believes it's unlikely there will be a supply problem and is encouraged by recent upticks in actual vaccinations. Tim O'Donnell
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
5 slow on the draw cartoons about Democrats' response to Trump
Cartoons Artists take on taking a stand, staying still as a statue, and more
By The Week US Published
-
A road trip through Zimbabwe
The Week Recommends The country is 'friendly and relaxed', with plenty to see for those who wish to explore
By The Week UK Published
-
The assassination of Malcolm X
The Explainer The civil rights leader gave furious clarity to black anger in the 1960s, but like several of his contemporaries met with a violent end
By The Week UK Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published